Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.

scientific article

Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/IJLH.12257
P698PubMed publication ID24845343

P50authorYeung-Chul MunQ45532628
P2093author name stringW S Chung
J Huh
H J Huh
C M Seong
C Hahm
P2860cites workPrevalence and prognostic impact of allelic imbalances associated with leukemic transformation of Philadelphia chromosome-negative myeloproliferative neoplasmsQ24595117
Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international studyQ34037065
Cytogenetic and molecular aspects of Philadelphia negative chronic myeloproliferative disorders: clinical implicationsQ36769185
Conventional cytogenetics in myelofibrosis: literature review and discussionQ37367516
Application of array-based whole genome scanning technologies as a cytogenetic tool in haematological malignanciesQ37534893
Pathogenesis and consequences of uniparental disomy in cancerQ37868831
High-resolution single-nucleotide polymorphism array-profiling in myeloproliferative neoplasms identifies novel genomic aberrationsQ40108060
JAK2 V617F mutational status predicts progression to large splenomegaly and leukemic transformation in primary myelofibrosis.Q40181513
Cytogenetic studies at diagnosis in polycythemia vera: clinical and JAK2V617F allele burden correlatesQ46849228
Two routes to leukemic transformation after a JAK2 mutation-positive myeloproliferative neoplasm.Q50574544
Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations, and role in leukemic transformation.Q50721189
Leukemic blasts in transformed JAK2-V617F-positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation.Q51761197
Cytogenetic abnormalities in essential thrombocythemia: prevalence and prognostic significance.Q51805169
Conventional cytogenetics of myeloproliferative diseases other than CML contribute valid information.Q51978963
Identification of genomic aberrations associated with disease transformation by means of high-resolution SNP array analysis in patients with myeloproliferative neoplasm.Q53281116
Association of JAK2 mutation status and cytogenetic abnormalities in myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms.Q53287852
A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications.Q53312448
P433issue2
P304page(s)181-189
P577publication date2014-05-21
P1433published inInternational Journal of Laboratory HematologyQ15751320
P1476titleGenomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.
P478volume37

Reverse relations

cites work (P2860)
Q34749608Clinical relevance of high-resolution single nucleotide polymorphism array in patients with relapsed acute lymphoblastic leukemia with normal karyotype: a report of three cases
Q38860767Genomic profiling and directed ex vivo drug analysis of an unclassifiable myelodysplastic/myeloproliferative neoplasm progressing into acute myeloid leukemia

Search more.